Paper21685232
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Munger KL and 4 others. Mult Scler, 2011. Cited by 166 papers, by iCite.
Cite this record
ConductScience Library. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Papers, record 21685232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21685232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| Biomarkers | Major topic |
| Epstein-Barr Virus Infections | Major topic |
| Multiple Sclerosis | Major topic |
| Adolescent | |
| Adult | |
| Area Under Curve | |
| Case-Control Studies | |
| Epstein-Barr Virus Nuclear Antigens | |
| Female | |
| Humans | |
| Male | |
| Military Personnel | |
| Prospective Studies | |
| ROC Curve | |
| Radioimmunoassay | |
| Risk Factors | |
| United States | |
| Vitamin D | |
| Young Adult |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 NS042194 | NINDS NIH HHS | United States | R01NS042194 | PubMed and NIH | NIH RePORTER |
| R01 NS046635 | NINDS NIH HHS | United States | R01NS046635 | PubMed and NIH | NIH RePORTER |
| NS042194 | NINDS NIH HHS | United States | R01NS042194 | PubMed and NIH | NIH RePORTER |
| NS046635 | NINDS NIH HHS | United States | R01NS046635 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07924410 | Tele-rehabilitation Program in People With Multiple Sclerosis and Mild Disability | Background |
Source ClinicalTrials.gov
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15841210 | Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15841210 | PubMed |
| 2 | 17984305 | Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. | J Exp Med | 2007 | https://conductscience.org/library/papers/17984305 | PubMed |
| 3 | 19638446 | Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. | Brain | 2009 | https://conductscience.org/library/papers/19638446 | PubMed |
| 4 | 11021623 | Epstein-Barr virus and multiple sclerosis. | Epidemiology | 2000 | https://conductscience.org/library/papers/11021623 | PubMed |
| 5 | 12453804 | The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. | Am J Public Health | 2002 | https://conductscience.org/library/papers/12453804 | PubMed |
| 6 | 20824132 | An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. | PLoS One | 2010 | https://conductscience.org/library/papers/20824132 | PubMed |
| 7 | 14982728 | Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells. | J Neurovirol | 2004 | https://conductscience.org/library/papers/14982728 | PubMed |
| 8 | 19917644 | Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. | Brain | 2010 | https://conductscience.org/library/papers/19917644 | PubMed |
| 9 | 17179460 | Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. | JAMA | 2006 | https://conductscience.org/library/papers/17179460 | PubMed |
| 10 | 12653848 | Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. | Clin Exp Immunol | 2003 | https://conductscience.org/library/papers/12653848 | PubMed |
| 11 | 16569670 | Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. | Brain | 2006 | https://conductscience.org/library/papers/16569670 | PubMed |
| 12 | 17329717 | HLA-DR15 haplotype and multiple sclerosis: a HuGE review. | Am J Epidemiol | 2007 | https://conductscience.org/library/papers/17329717 | PubMed |
| 13 | 20237306 | EBV and brain matter(s)? | Neurology | 2010 | https://conductscience.org/library/papers/20237306 | PubMed |
| 14 | 15100207 | Epstein-Barr virus in pediatric multiple sclerosis. | JAMA | 2004 | https://conductscience.org/library/papers/15100207 | PubMed |
| 15 | 16502434 | Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. | Ann Neurol | 2006 | https://conductscience.org/library/papers/16502434 | PubMed |
| 16 | 15210894 | An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. | Neurology | 2004 | https://conductscience.org/library/papers/15210894 | PubMed |
| 17 | 19525955 | Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. | Nat Genet | 2009 | https://conductscience.org/library/papers/19525955 | PubMed |
| 18 | 3007606 | 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. | J Immunol | 1986 | https://conductscience.org/library/papers/3007606 | PubMed |
| 19 | 20220124 | Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. | Neurology | 2010 | https://conductscience.org/library/papers/20220124 | PubMed |
| 20 | 17492755 | Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. | Ann Neurol | 2007 | https://conductscience.org/library/papers/17492755 | PubMed |
Cited by90
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42956321 | Epstein-Barr Virus Serologic Profiles in Multiple Sclerosis and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. | Neurol Neuroimmunol Neuroinflamm | 2027 | https://conductscience.org/library/papers/42956321 | PubMed |
| 42898310 | High EBV-reactive IgG levels in serum are linked to typical inflammatory cerebrospinal fluid features in multiple sclerosis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42898310 | PubMed |
| 42743450 | EBNA1381-452 and Cross-Reactive Antibody Responses Reveal Immune Signatures in Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2026 | https://conductscience.org/library/papers/42743450 | PubMed |
| 42654984 | Epstein-Barr Virus and Multiple Sclerosis: Mechanistic Insights into Virus-Driven Autoimmunity. | Microorganisms | 2026 | https://conductscience.org/library/papers/42654984 | PubMed |
| 42112902 | Epstein-Barr virus receptors: classification, functional mechanisms, and pathogenic implications. | J Virol | 2026 | https://conductscience.org/library/papers/42112902 | PubMed |
| 41919465 | Why Is MS a More Frequent Complication of EBV Infection in Females? | Immunol Rev | 2026 | https://conductscience.org/library/papers/41919465 | PubMed |
| 41707657 | Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41707657 | PubMed |
| 41235241 | Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair. | Front Immunol | 2025 | https://conductscience.org/library/papers/41235241 | PubMed |
| 41098679 | Emerging Insights into the Role of Macrophages in Multiple Sclerosis: Pathogenesis and Potential Therapeutic Strategies. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/41098679 | PubMed |
| 40970118 | Intrathecally expanded GZMK+/GZMH+ CD8 T cells targeting EBV antigens may reduce severity of Multiple Sclerosis. | medRxiv | 2025 | https://conductscience.org/library/papers/40970118 | PubMed |
| 40953326 | Epstein-Barr Virus in Multiple Sclerosis: Past, Present, and Future. | Neurol Neuroimmunol Neuroinflamm | 2025 | https://conductscience.org/library/papers/40953326 | PubMed |
| 40636815 | Multiple sclerosis: 2024 update. | Free Neuropathol | 2025 | https://conductscience.org/library/papers/40636815 | PubMed |
| 39962592 | Knowledge mapping of childhood infectious mononucleosis: a bibliometric analysis for the twenty-first century. | J Health Popul Nutr | 2025 | https://conductscience.org/library/papers/39962592 | PubMed |
| 39776919 | EBV-specific T-cell immunity: relevance for multiple sclerosis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39776919 | PubMed |
| 39524581 | Epstein-Barr virus flare: A multiple sclerosis attack. | Surg Neurol Int | 2024 | https://conductscience.org/library/papers/39524581 | PubMed |
| 39505801 | Research landmarks on the 60th anniversary of Epstein-Barr virus. | Sci China Life Sci | 2025 | https://conductscience.org/library/papers/39505801 | PubMed |
| 38843296 | Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/38843296 | PubMed |
| 38361801 | Insights into the interplay between Epstein-Barr virus (EBV) and multiple sclerosis (MS): A state-of-the-art review and implications for vaccine development. | Health Sci Rep | 2024 | https://conductscience.org/library/papers/38361801 | PubMed |
| 38338973 | A Blood Test for the Diagnosis of Multiple Sclerosis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38338973 | PubMed |
| 38338799 | Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38338799 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| HLA-DRB1 | 3123 | PubTator's text mining | https://conductscience.org/library/genes/3123 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21685232
GET https://conductscience.org/api/papers/v1/21685232/references?page=2